Skip to content

Investigating cognitive training tasks to reduce heavy drinking

Investigating cognitive training tasks to reduce heavy drinking: a randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN35503634
Enrollment
32
Registered
2019-01-18
Start date
2017-07-14
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heavy alcohol use Mental and Behavioural Disorders Mental and behavioural disorders due to use of alcohol

Interventions

Sponsors

University of Manchester
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Consumption of 21 or more units of alcohol per week but not meeting SCID criteria for dependence

Exclusion criteria

Exclusion criteria: 1. Participants must not meet criteria for alcohol dependence as per the Structured Clinical Interview for Depression (SCID) (as assessed at online screening and during baseline interview) 2. Positive drug/alcohol screens on testing visits. A minimum list of drugs that will be screened for include amphetamines, barbiturates, cocaine, opiates, cannabinoids and benzodiazepines. Positive results for cannabinoids will be allowed given the long half-life of cannabinoid metabolites. This exclusion criterion would exclude a subject from completing the study on that day only and not the study as a whole, at the discretion of the research team 3. High dosage use of regular psychoactive prescription medications such as those with antidepressant or anxiolytic properties. 4. History or presence of a neurological diagnosis (not limited to but including, for example, stroke, epilepsy, space occupying lesions, multiple sclerosis, Parkinson's disease, vascular dementia, transient ischemic attack) that may influence the outcome of any cognitive testing 5. Clinically significant head injury (e.g., requiring medical or surgical intervention) 6. Unwillingness or inability to follow the procedures outlined in the protocol 7. Significant current or past psychiatric history, including Major Depression, Generalised Anxiety Disorders, or anything that involves referral to secondary services and/or significant functional impairment 8. Neuroendocrine disorder, including impaired thyroid function and steroid use 9. Female participants who are, or may be, pregnant 10. Those with any contraindications for MRI scanning will be excluded

Design outcomes

Primary

MeasureTime frame
Alcohol consumption measured using a 28-day Timeline Followback at baseline and one month follow-up

Secondary

MeasureTime frame
1. Cognition measured using reaction times and errors on the Approach Avoidance and Visual Probe tasks at a single session 2. Blood-oxygen-level dependent (BOLD) activity assessed using MR techniques at a single session

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 20, 2026